COMMUNIQUÉS West-GlobeNewswire

Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

05/01/2018 - 14:00

Retrophin obtains exclusive option to purchase Censa post proof-of-concept study Phase 2 proof-of-concept study in PKU patients expected to commence in mid-2018 SAN DIEGO, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, [...]

Helius Medical Technologies Selects Key Tronic Corporation as its Commercial Contract Manufacturing Partner

05/01/2018 - 14:00

NEWTOWN, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, [...]

Zealand Pharma to attend Oddo BHF Forum on January 12, 2018

05/01/2018 - 13:53

Press release - No. 1 / 2018 Zealand Pharma to attend Oddo BHF Forum on January 12, 2018 Copenhagen, 5 January, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be [...]

Biohit Oyj’s comments on its Chinese distributor’s announcement

05/01/2018 - 13:30

Biohit Oyj company release 5.1.2018 klo 14:30 local time (EEST) Biohit Oyj does not normally comment on its distributors or other third parties announcements, but due to details presented in the media and the potential [...]

ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 - 11, 2018

05/01/2018 - 13:01

Geneva, Switzerland and Boston, MA - January 5, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]

miRagen Therapeutics Expands Board of Directors with Appointment of Arlene Morris

05/01/2018 - 13:00

BOULDER, Colo., Jan. 05, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced [...]

Idera Pharmaceuticals Provides 2018 Update and Outlook

05/01/2018 - 13:00

EXTON, Pa. and CAMBRIDGE, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of [...]

AxoGen to Participate at AAHS ASPN ASRM 2018 Annual Meetings

05/01/2018 - 13:00

ALACHUA, Fla., Jan. 05, 2018 (GLOBE NEWSWIRE) -- AxoGen Corporation (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve damage, today announced its [...]

Surgery Partners Announces Appointment of Wayne S. DeVeydt as Chief Executive Officer

05/01/2018 - 13:00

NASHVILLE, Tenn., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) (the “Company”), a leading healthcare services company, today announced the appointment of Wayne S. DeVeydt as Chief Executive [...]

Axovant to Present at 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 13:00

BASEL, Switzerland, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXON ) today announced that its Chief Executive Officer David Hung, MD, will be presenting at the 36th Annual J.P. Morgan Healthcare [...]

Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit

05/01/2018 - 13:00

PLEASANTON, Calif., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced it has named Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit. Ms [...]

Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018

05/01/2018 - 13:00

ZGN-1061 Phase 2 trial fully enrolled with type 2 diabetes patients; topline data expected mid-year Company returning to rare disorders with ZGN-1258; Prader-Willi syndrome expected as first indication Increased cash [...]

Dentsply Sirona to Present at the 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 13:00

YORK, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the company will present at the 36 th Annual J.P. Morgan [...]

Chimerix Initiates AdAPT Study for Oral Brincidofovir and Advances IV Brincidofovir to Patient Studies

05/01/2018 - 13:00

- Pivotal AdAPT Study of Oral Brincidofovir for Adenovirus Now Enrolling - - No GI Adverse Effects for IV Brincidofovir 10 mg - - Announces First Antiviral Specific for Norovirus Now In Clinical Testing - DURHAM, N.C., [...]

OraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference

05/01/2018 - 12:00

BETHLEHEM, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, [...]

Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD

05/01/2018 - 12:00

NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ: OHRP ), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported topline data from the MAKO [...]

BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossificans Progressiva

05/01/2018 - 12:00

RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today that it has advanced a program exploring activin receptor-like kinase-2 (ALK2) inhibitors [...]

TLC to Attend and Present at the 36th Annual JP Morgan Healthcare Forum

05/01/2018 - 11:00

TAIPEI, Taiwan, Jan. 05, 2018 (GLOBE NEWSWIRE) -- TLC (4152.TWO) today announced that it will be attending the 36 th annual JP Morgan Healthcare Conference in San Francisco on January 7-11, 2018. TLC President George [...]

Lundbeck enters research partnership on novel treatment of schizophrenia

05/01/2018 - 08:00

Valby, 2018-01-05 08:00 CET (GLOBE NEWSWIRE) -- H. Lundbeck A/S (Lundbeck) now adds another novel approach to its efforts to research and develop new and better treatments for schizophrenia. Forming a partnership with [...]